Knobbe Martens | USA | 30 May 2023
On April 25th, 2023, the U.S. Food and Drug Administration (FDA) approved QalsodyTM (tofersen) for the treatment of amyotrophic lateral sclerosis…
Knobbe Martens | USA | 30 May 2023
Brain computer interface developer Paradromics on May 18, 2023, announced a $33 million Series A funding round as well as a “Breakthrough Device…
Knobbe Martens | USA | 25 May 2023
Medtronic filed five IPRs against patents related to catheters, relying on a single prior art reference under pre-AIA 35 U.S.C 102(e). Teleflex…
Knobbe Martens | USA | 25 May 2023
OneSubsea UK Limited and OneSubsea LLC (together “OSS”) asserted three patents against FMC Technologies, Inc. (“FMC”). The patents related to…
Knobbe Martens | USA | 22 May 2023
As predictions of an economic recession in the United States loom, 2023 has started with extensive layoffs throughout the tech industry. Though not…
Knobbe Martens | USA | 22 May 2023
In Ironburg Inventions Ltd. v. Valve Corp., Appeal No. 21-2296, the Federal Circuit held that the patentee has the burden of proving that invalidity…
Knobbe Martens | USA | 12 May 2023
DuPont announced on May 2, 2023 its acquisition of Spectrum Plastics Group (“Spectrum”), a specialty plastics manufacturer, from the private equity…
Knobbe Martens | European Union, USA | 10 May 2023
On April 26, 2023, the European Commission proposed a pharmaceutical law reform directed to replacing the existing pharmaceutical legislation. The…